We are live on
!
Find out more
RAM
Readystate Asset Management Portfolio holdings
AUM
$2.23B
1-Year Est. Return
15%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+15%
3 Year Est. Return
+34.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.27B
AUM Growth
+$265M
(+8.8%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-23.81%
Top 10 Holdings %
Top 10 Hldgs %
40.43%
Holding
979
New
382
Increased
76
Reduced
85
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hershey
HSY
|
+$72.5M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$45.4M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$34.3M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$31.8M |
| 5 |
Avantor
AVTR
|
+$27.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$66.9M |
| 2 |
K
Kellanova
K
|
+$60.1M |
| 3 |
FYBR
Frontier Communications
FYBR
|
+$50.1M |
| 4 |
X
US Steel
X
|
+$34.4M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$31.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.19% |
| 2 | Technology | 6.26% |
| 3 | Consumer Discretionary | 3.33% |
| 4 | Consumer Staples | 2.88% |
| 5 | Communication Services | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Sally Beauty Holdings
SBH
$1.4B
| – | – |
-185,645
| Closed | -$1.68M |
|
852
CALL
Starbucks
SBUX
$118B
| – | – |
-31,000
| Closed | -$3.04M |
|
|
853
Starbucks
SBUX
$118B
| – | – |
-15,305
| Closed | -$1.5M |
|
|
854
PUT
Starbucks
SBUX
$118B
| – | – |
-21,700
| Closed | -$2.13M |
|
|
SCHW
855
CALL
Charles Schwab
SCHW
$177B
| – | – |
-48,400
| Closed | -$3.79M |
|
|
SCHW
856
PUT
Charles Schwab
SCHW
$177B
| – | – |
-40,400
| Closed | -$3.16M |
|
857
Scansource
SCSC
$1.12B
| – | – |
-29,771
| Closed | -$1.01M |
|
858
Snap
SNAP
$7.32B
| – | – |
-45,264
| Closed | -$394K |
|
859
SoundHound AI
SOUN
$2.68B
| – | – |
-14,410
| Closed | -$117K |
|
860
CALL
S&P Global
SPGI
$126B
| – | – |
-6,200
| Closed | -$3.15M |
|
|
861
S&P Global
SPGI
$126B
| – | – |
-1,405
| Closed | -$714K |
|
|
862
PUT
S&P Global
SPGI
$126B
| – | – |
-6,500
| Closed | -$3.3M |
|
863
Shattuck Labs
STTK
$710M
| – | – |
-11,049
| Closed | -$10.5K |
|
864
Savara
SVRA
$1.13B
| – | – |
-522,791
| Closed | -$1.45M |
|
865
CALL
Stryker
SYK
$127B
| – | – |
-7,100
| Closed | -$2.64M |
|
|
866
Stryker
SYK
$127B
| – | – |
-2,369
| Closed | -$882K |
|
|
867
PUT
Stryker
SYK
$127B
| – | – |
-9,500
| Closed | -$3.54M |
|
868
CALL
AT&T
T
$165B
| – | – |
-116,500
| Closed | -$3.29M |
|
|
869
PUT
AT&T
T
$165B
| – | – |
-128,300
| Closed | -$3.63M |
|
870
iShares TIPS Bond ETF
TIP
$14.5B
| – | – |
-30,205
| Closed | -$3.36M |
|
871
CALL
TJX Companies
TJX
$170B
| – | – |
-30,700
| Closed | -$3.74M |
|
|
872
TJX Companies
TJX
$170B
| – | – |
-1,808
| Closed | -$220K |
|
|
873
PUT
TJX Companies
TJX
$170B
| – | – |
-19,700
| Closed | -$2.4M |
|
874
CALL
Thermo Fisher Scientific
TMO
$211B
| – | – |
-5,400
| Closed | -$2.69M |
|
|
875
Thermo Fisher Scientific
TMO
$211B
| – | – |
-691
| Closed | -$344K |
|
Similar funds
DPCM
IFA
NP
ML
GF
NLGIA
BOI
GCM
Readystate Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Readystate Asset Management held 979 positions worth $3.27B, up 8.8% from $3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Readystate Asset Management withdrew a net $778M in Q2 2025, closing 388 positions and reducing 85 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $66.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 6.5% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Readystate Asset Management opened a new position in Hershey worth $73M.
- Readystate Asset Management's largest Q2 2025 buy was Hershey: 440,026 shares worth $73M.
- Readystate Asset Management added most to Exact Sciences in Q2 2025, an estimated $45.4M increase.
- Readystate Asset Management's biggest Q2 2025 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $31.8M.
- Readystate Asset Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $66.9M.
- Readystate Asset Management's ten largest holdings make up 40% of its $3.27B portfolio in Q2 2025.
- Readystate Asset Management opened 382 new positions and closed 388 in Q2 2025.
- Readystate Asset Management's portfolio value rose 8.8% quarter-over-quarter to $3.27B.
Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.